By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CoLucid Pharmaceuticals, Inc. 

902 North Capitol Avenue
Suite 302
Indianapolis  Indiana  46204  U.S.A.
Phone: 317-684-6703 Fax:



Company News
CoLucid Pharma (CLCD) Announces 2016 Second Quarter Results and Corporate Highlights 8/10/2016 11:00:45 AM
CoLucid Pharma (CLCD) Completes Enrollment for SAMURAI Phase III Study Evaluating Oral Lasmiditan 6/8/2016 2:11:28 PM
CoLucid Pharma (CLCD) And IMS Health Publish White Paper To Address Migraine Market Misperceptions 1/5/2016 8:18:12 AM
CoLucid Pharma (CLCD) Announces Appointment Of Dr. Raymond Skwierczynski As Head, Pharmaceutical Operations 12/8/2015 11:19:47 AM
CoLucid Pharma (CLCD) Provides SAMURAI Enrollment Update 11/30/2015 7:20:35 AM
CoLucid Pharma (CLCD) To Present Corporate Overview At The Stifel 2015 Healthcare Conference 11/12/2015 8:29:06 AM
CoLucid Pharma (CLCD) Announces Third Quarter 2015 Results And Corporate Highlights 11/10/2015 8:17:25 AM
CoLucid Pharma (CLCD) Announces Election Of Mark Corrigan, M.D., To Board Of Directors 10/27/2015 7:44:50 AM
CoLucid Pharma (CLCD) Announces Initiation Of Phase III Long-Term, Open-Label Trial Of Lasmiditan In Migraine 10/8/2015 7:17:45 AM
CoLucid Pharma To Present At Two Investor Conferences In September 9/3/2015 7:28:49 AM